60
Participants
Start Date
January 31, 2009
Primary Completion Date
June 30, 2010
Study Completion Date
June 30, 2010
Linezolid or Vancomycin
Whole blood samples from healthy subjects will be incubated with MRSA bacterium or bacterial toxins in the presence and absence of either linezolid or vancomycin. Final concentrations will mimic physiologic conditions. Platelets and leukocytes will be isolated and assayed for the presence of absence of activation and pre-mRNA splicing.
Collaborators (1)
Pfizer
INDUSTRY
University of Utah
OTHER